The first target on the trial was to determine if Anastrozole could increase the length of “disease-no cost survival” for that participating clients. Disease-cost-free survival is described because the interval after medicines and/or treatment plans are stopped ahead of the patient’s most cancers returns. During the demo, scientists tracked g